Morgan Stanley’s Advantest Corp ATE Stock Holding History

Morgan Stanley’s Portfolio ATE Stock Details ATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-74,980	Closed	-$695K	–	6922
2016 Q1	$695K	Buy	+74,980	New	+$671K	﹤0.01%	4213
2015 Q3	–	Sell	-190	Closed	-$1.64K	–	6892
2015 Q2	$2K	Hold	190	–	–	﹤0.01%	6541
2015 Q1	$2K	Hold	190	–	–	﹤0.01%	6458
2014 Q4	$2K	Hold	190	–	–	﹤0.01%	6462
2014 Q3	$2K	Hold	190	–	–	﹤0.01%	6464
2014 Q2	$2K	Sell	190 -1	-0.5%	-$11	﹤0.01%	6411
2014 Q1	$2K	Hold	191	–	–	﹤0.01%	6368
2013 Q4	$2K	Buy	+191	New	+$2.33K	﹤0.01%	6274

Other funds holding ATE

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

WAM

World Asset Management Detroit, Michigan $1.01B AUM 42.4% 1-Year Est. Return

CIM

Calvert Investment Management Bethesda, Maryland $2.67B AUM 16.23% 1-Year Est. Return

CCA

Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return

Morgan Stanley's ATE Position: Q2 2016 in Review

Morgan Stanley sold out of Advantest Corp (ATE) in Q2 2016, closing a stake of 74,980 shares — an estimated $695K sold.

Morgan Stanley first reported a position in ATE in Q4 2013 and held it in 8 quarters. The position peaked at $695K in Q1 2016. 5 funds tracked by Wall St. Rank hold ATE as of Q2 2016.

Morgan Stanley reported no remaining Advantest Corp position as of Q2 2016 after selling out during the quarter.
Morgan Stanley sold 74,980 Advantest Corp shares in Q2 2016, an estimated $695K.
Morgan Stanley first reported a position in Advantest Corp in Q4 2013 and held it in 8 quarters.
Morgan Stanley's Advantest Corp position peaked at $695K in Q1 2016.
5 funds tracked by Wall St. Rank held Advantest Corp as of Q2 2016.

Based on Morgan Stanley's 13F filing for Q2 2016, filed 12 Aug 2016.